Does Adjuvant Therapy Work in Colon Cancer?
- 8 February 1990
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 322 (6) , 399-401
- https://doi.org/10.1056/nejm199002083220610
Abstract
Colorectal carcinoma is second only to lung cancer as a cause of death from cancer in the United States. Although the majority of patients found to have a large-bowel tumor successfully undergo a removal of all gross tumor, 40 to 50 percent are found at the time of surgery to have invasion of the tumor through the serosa (Stage B2) or spread to regional lymph nodes (Stage C). The prognosis after such "complete" resection is closely related to surgical stage. The prognosis for each stage appears to have improved somewhat in recent years, most likely because of more . . .Keywords
This publication has 9 references indexed in Scilit:
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.Journal of Clinical Oncology, 1989
- Toxicity of Levamisole and 5-Fluorouracil in Human Colon Carcinoma CellsJNCI Journal of the National Cancer Institute, 1989
- Status of Adjuvant Therapy for Colorectal CancerJNCI Journal of the National Cancer Institute, 1989
- Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double-blind randomized clinical trialBritish Journal of Surgery, 1989
- Adjuvant Therapy of Colorectal CancerPublished by American Medical Association (AMA) ,1988
- Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancerBritish Journal of Surgery, 1987
- A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.Journal of Clinical Oncology, 1985